J 2021

Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant

ŠTORK, Martin, Renata BEZDĚKOVÁ, Romana KRÁLOVÁ, Viera SANDECKÁ, Zdeněk ADAM et. al.

Basic information

Original name

Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant

Authors

ŠTORK, Martin (203 Czech Republic), Renata BEZDĚKOVÁ (203 Czech Republic), Romana KRÁLOVÁ (203 Czech Republic), Viera SANDECKÁ (703 Slovakia, guarantor), Zdeněk ADAM (203 Czech Republic), Marta KREJČÍ (203 Czech Republic), Ivanna BOICHUK (804 Ukraine), Zdeňka KNECHTOVÁ (203 Czech Republic), Lucie BROŽOVÁ (203 Czech Republic), Sabina ŠEVČÍKOVÁ (203 Czech Republic, belonging to the institution), Lucie ŘÍHOVÁ (203 Czech Republic) and Luděk POUR (203 Czech Republic)

Edition

Neoplasma, Bratislava, Slovenská akademie vied, 2021, 0028-2685

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Slovakia

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.409

RIV identification code

RIV/00216224:14110/21:00120121

Organization unit

Faculty of Medicine

UT WoS

000662144000007

Keywords in English

multiple myeloma; minimal residual disease; lymphocyte; flow cytometry

Tags

Tags

International impact, Reviewed
Změněno: 23/8/2021 11:02, Mgr. Tereza Miškechová

Abstract

V originále

Despite the high efficacy of current induction regimens, most multiple myeloma (MM) patients relapse over time. The link between changes in the immune system and the prognosis of the disease is still not entirely clear. Therefore, we analyzed whether the pattern of bone marrow (BM) lymphocytes during routine BM examination after autologous stem cell transplant (ASCT) is related to disease prognosis or MRD negative complete remission. From 2009 to 2018, 98 MM patients underwent routine BM testing after the first ASCT. Using multi-parametric flow cytometry, twelve BM lymphocyte subtypes were analyzed. In 60% of patients who achieved a complete response (CR), MRD by flow cytometric analysis (sensitivity threshold 10-6) was evaluated. We found an association of relative proportion of BM lymphocyte subtypes with treatment response, progression-free survival (PFS), overall survival (OS), and minimal residual disease (MRD) negativity. Higher relative proportion of memory B cells was associated with inferior median PFS [HR 1.089 (95% CI: 1.023-1.160), p=0.0081 and median OS [HR 1.170 (95% CI: 1.074-1.274), p<0.001]. In non-responding patients (minimal response and worse), higher proportion of memory B cells was found when compared to patients achieving CR [3.8% (range 0.5-35.0) vs. 1.0% (range 0.1-12.5); p=0.0011. No significant association of BM lymphocyte subtypes proportion with MRD negative CR was found. Our results show that changes in BM lymphocyte subsets including memory B cells may have prognostic value in MM patients after ASCT.

Links

NV17-29343A, research and development project
Name: Analýza mikroprostředí kostní dřeně u extramedulárního relapsu mnohočetného myelomu